Personalized Cancer Medicine project started. First samples being sequenced
We have started the sequencing of the first samples for the National Personalized Cancer Medicine project lead by the Norwegian Cancer Genomics Consortium. Approximately 200 samples from human melanoma patients will be exome sequenced using Agilent SureSelect Human All Exome V5 target enrichment technology.
We have started the sequencing of the first samples for the National Personalized Cancer Medicine project lead by the Norwegian Cancer Genomics Consortium. Approximately 200 samples from human melanoma patients will be exome sequenced using Agilent SureSelect Human All Exome V5 target enrichment technology.
News
The Genomics Core Facility has successfully gone through a certification process to become a certified NGS ProLab for TWIST Bioscience technologies.
The Genomics Core Facility at Oslo University Hospital and University of Oslo is now a Core Lab for nCounter and GeoMx technologies.
Contact Information:
Genomics@rr-research.no
Daily Leader Core Facility
Susanne Lorenz, PhD
Susanne.Lorenz@rr-research.no
Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.
L.A.Meza-Zepeda@ous-research.no
Follow us via Twitter
Visiting address:
Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building
Norwegian Radium Hospital
Ullernchaussen 66, Lamell 3, 2B
NO-0379 Oslo, NORWAY
+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office
................................................................